{"id":"https://openalex.org/W2076375479","doi":"https://doi.org/10.1111/j.1365-2125.2008.03270.x","title":"Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses","display_name":"Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses","alternate_titles":[],"publication_year":2008,"publication_date":"2008-11-20","ids":{"openalex":"https://openalex.org/W2076375479","doi":"https://doi.org/10.1111/j.1365-2125.2008.03270.x","mag":"2076375479","pmid":"https://pubmed.ncbi.nlm.nih.gov/19032723","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2675769"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.2008.03270.x","doi":"https://doi.org/10.1111/j.1365-2125.2008.03270.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2008.03270.x","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2076375479"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2675769/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040398083","display_name":"Paul Edward Rolan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Rolan","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Adelaide, Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113595725","display_name":"Jacqueline A. Gibbons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacqueline A. Gibbons","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Adelaide, Australia, JG Consulting, Piedmont and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Adelaide, Australia, JG Consulting, Piedmont and","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101697557","display_name":"Lin He","orcid":"https://orcid.org/0000-0002-1897-6090","observed_orcids":["https://orcid.org/0000-0002-1897-6090"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lin He","raw_affiliation_strings":["Avigen Inc., Alameda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avigen Inc., Alameda, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008389895","display_name":"Eppie Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eppie Chang","raw_affiliation_strings":["Avigen Inc., Alameda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avigen Inc., Alameda, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Drew Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Drew Jones","raw_affiliation_strings":["Avigen Inc., Alameda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avigen Inc., Alameda, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111380618","display_name":"Matthew I. Gross","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew I. Gross","raw_affiliation_strings":["Avigen Inc., Alameda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avigen Inc., Alameda, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038337407","display_name":"Jennifer Bahr Davidson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer Bahr Davidson","raw_affiliation_strings":["Avigen Inc., Alameda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avigen Inc., Alameda, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031339152","display_name":"Laura M. Sanftner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura M. Sanftner","raw_affiliation_strings":["Avigen Inc., Alameda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avigen Inc., Alameda, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111968998","display_name":"Kirk W. Johnson","orcid":"https://orcid.org/0000-0003-0849-508X","observed_orcids":["https://orcid.org/0000-0003-0849-508X"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kirk W. Johnson","raw_affiliation_strings":["Avigen Inc., Alameda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avigen Inc., Alameda, CA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111968998"],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.7806,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.88638122,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"66","issue":"6","first_page":"792","last_page":"801"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6362000107765198,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6362000107765198,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.11869999766349792,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.060100000351667404,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibudilast","display_name":"ibudilast","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9449999928474426},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.9559999704360962},{"id":"https://openalex.org/keywords/multiple-dose-regimen","display_name":"multiple-dose regimen","score":0.7110000252723694},{"id":"https://openalex.org/keywords/single-dose-administration","display_name":"single-dose administration","score":0.8510000109672546},{"id":"https://openalex.org/keywords/primary-metabolites","display_name":"primary metabolites","score":0.8610000014305115},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.6570000052452087},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.7329999804496765},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.36800000071525574},{"id":"https://openalex.org/keywords/lc-ms-ms-quantification","display_name":"LC-MS/MS quantification","score":0.7620000243186951},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.6880000233650208},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8856422901153564},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8089994192123413},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7623711824417114},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6482817530632019},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6402285099029541},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5867973566055298},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5857985019683838},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.4908788800239563},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.4630252420902252},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4593859016895294},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3524326682090759},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3489232659339905},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007212","descriptor_name":"Indolizines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1365-2125.2008.03270.x","doi":"https://doi.org/10.1111/j.1365-2125.2008.03270.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2008.03270.x","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2675769","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2675769/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:19032723","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19032723","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/53212","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2440/53212","pdf_url":null,"source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://doi.org/10.1111/j.1365-2125.2008.03270.x","raw_type":"Journal article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2675769","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2675769/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1948711363","https://openalex.org/W2015356286","https://openalex.org/W2064462697","https://openalex.org/W2077951941","https://openalex.org/W2079790110","https://openalex.org/W2103801183","https://openalex.org/W2131585639","https://openalex.org/W2336792834","https://openalex.org/W3154409123"],"related_works":["https://openalex.org/W2375685116","https://openalex.org/W1123985619","https://openalex.org/W2921813279","https://openalex.org/W2347865561","https://openalex.org/W2084586262","https://openalex.org/W1991198887","https://openalex.org/W2389939757","https://openalex.org/W2108139132","https://openalex.org/W2389739782","https://openalex.org/W2131585639"],"abstract_inverted_index":{"WHAT":[0,47],"IS":[1],"ALREADY":[2],"KNOWN":[3],"ABOUT":[4],"THIS":[5,48],"SUBJECT":[6],"\u2022":[7,18,27,51,74,85],"Ibudilast":[8,190,286],"is":[9,287],"an":[10],"oral":[11,37,153,299],"drug":[12],"approved":[13],"in":[14,42,68,81,140,237,291,342],"Asia":[15],"for":[16,79,88,175,183,244,312],"asthma.":[17],"Tolerability":[19],"of":[20,39,55,90,95,112,165,220,276,282,301,323,333],"10\u2010mg":[21],"regimens":[22,76],"has":[23],"been":[24],"described":[25],"previously.":[26],"Published":[28],"pharmacokinetics":[29,110],"(PK)":[30,111],"are":[31,77],"limited:":[32],"single":[33,57,159,298],"or":[34,155],"7\u2010day":[35],"repeat":[36],"administration":[38,160],"10":[40],"mg":[41,167,217,303,307,310],"healthy":[43,72,292],"male":[44,69,124],"Asian":[45],"volunteers.":[46,73],"STUDY":[49],"ADDS":[50],"Safety/tolerability":[52],"and":[53,60,70,92,98,109,117,128,178,185,206,239,249,260,267],"PK":[54,234,316],"a":[56,61,115,118,137,141,212,231,297,334],"30\u2010mg":[58,62,158],"dose":[59,300],"twice":[63],"daily":[64],"(b.i.d.)":[65],"2\u2010week":[66],"regimen":[67],"female":[71,129],"Higher\u2010dose":[75],"relevant":[78],"testing":[80],"new":[82],"neurological":[83],"indications.":[84],"LC\u2010MS/MS":[86],"analytics":[87],"quantification":[89],"plasma":[91,177,258],"urine":[93,179],"levels":[94,275],"ibudilast":[96,113,156,184,245,330],"parent":[97],"its":[99,186],"primary":[100],"metabolite":[101],"(6,7\u2010dihydrodiol\u2010ibudilast).":[102],"AIMS":[103],"To":[104],"investigate":[105],"the":[106,283,325],"safety,":[107],"tolerability":[108],"after":[114,211],"single\u2010dose":[116],"multiple\u2010dose":[119],"regimen.":[120,327],"METHODS":[121],"Healthy":[122],"adult":[123],"(n":[125,130],"=":[126,131],"9)":[127,132],"volunteers":[133],"were":[134,146,172,181,225,235,262,279],"evaluated":[135],"over":[136],"17\u2010day":[138],"stay":[139],"Phase":[142],"1":[143,148],"unit.":[144],"Subjects":[145],"randomized":[147],":":[149],"3":[150],"to":[151,228,329,337],"either":[152],"placebo":[154],"at":[157,215],"followed":[161,304],"by":[162,305],"14":[163,313],"days":[164,214,322],"30":[166,216,302,306],"b.i.d.":[168,218,308,326],"Complete":[169],"safety":[170],"analyses":[171],"performed":[173],"and,":[174],"PK,":[176],"samples":[180,223],"analysed":[182],"major":[187],"metabolite.":[188],"RESULTS":[189],"was":[191,246,252,331],"generally":[192,288],"well":[193,289],"tolerated.":[194],"No":[195],"serious":[196],"adverse":[197,201],"events":[198,202],"occurred.":[199],"Treatment\u2010related":[200],"included":[203],"hyperhidrosis,":[204],"headache":[205],"nausea.":[207],"Two":[208],"subjects":[209],"discontinued":[210],"few":[213],"because":[219],"vomiting.":[221],"Although":[222],"sizes":[224],"too":[226],"small":[227],"rule":[229],"out":[230],"sex":[232],"difference,":[233],"similar":[236],"men":[238],"women.":[240],"The":[241],"mean":[242],"half\u2010life":[243],"19":[247],"h":[248,271],"median":[250],"Tmax":[251],"4\u20136":[253],"h.":[254],"Mean":[255],"(SD)":[256],"steady\u2010state":[257],"Cmax":[259],"AUC0\u201324":[261],"60":[263],"(25)":[264],"ng":[265,270],"ml\u22121":[266],"1004":[268],"(303)":[269],"ml\u22121,":[272],"respectively.":[273],"Plasma":[274,315],"6,7\u2010":[277],"dihydrodiol\u2010ibudilast":[278],"approximately":[280],"30%":[281],"parent.":[284],"CONCLUSIONS":[285],"tolerated":[290],"adults":[293],"when":[294],"given":[295],"as":[296],"(60":[309],"day\u22121)":[311],"days.":[314],"reached":[317],"steady":[318],"state":[319],"within":[320],"2":[321],"starting":[324],"Exposure":[328],"achieved":[332],"magnitude":[335],"comparable":[336],"that":[338],"associated":[339],"with":[340],"efficacy":[341],"rat":[343],"chronic":[344],"pain":[345],"models.":[346]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2076375479","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
